| Literature DB >> 14323662 |
Abstract
The diagnosis of myasthenia gravis is often difficult and calls for a broader use of pharmacological and electrodiagnostic tests. The decamethonium-edrophonium test, which has proved superior to other procedures for this purpose, is based on neurophysiological principles and depicts the behaviour of the neuromuscular junction. A state of resistance to depolarizing agents in the limited form of myasthenia and a state of a non-depolarizing (competitive) block in advanced cases has been shown. This test has demonstrated that the neuromuscular defect exists throughout the skeletal musculature, including muscles clinically unaffected. It produced no false-positive results either in normal or neurasthenic persons or in patients with neurological diseases with myasthenic symptoms. In a patient with botulism and in a patient with ocular palsies from brain-stem encephalitis the edrophonium test gave a false-positive result, while the decamethonium-edrophonium test was negative.Diagnosis, treatment and management of myasthenic emergencies are described.Entities:
Keywords: ACETYLCHOLINE; BOTULISM; BROMIDES; CHOLINESTERASE INHIBITORS; CURARIFORM ANTAGONISTS; DECAMETHONIUM COMPOUNDS; DIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY; EDROPHONIUM CHLORIDE; ELECTRODIAGNOSIS; ENCEPHALITIS; MYASTHENIA GRAVIS; NEUROMUSCULAR SPINDLES; NEUROSES; PHARMACOLOGY; POTASSIUM CHLORIDE; PREGNANCY; PREGNANCY COMPLICATIONS; SPIRONOLACTONE; THYMECTOMY
Mesh:
Substances:
Year: 1965 PMID: 14323662 PMCID: PMC1928601
Source DB: PubMed Journal: Can Med Assoc J ISSN: 0008-4409 Impact factor: 8.262